Conditions: Multiple Myeloma Non-Hodgkin Lymphoma Acute Myeloid Leukemia Acute Lymphoid Leukemia Chronic Myeloid Leukemia
Keywords: multiple myeloma [MM] non-Hodgkin lymphoma [NHL] acute myeloid leukemia [AML] acute lymphoid leukemia [ALL] chronic myeloid leukemia [CML]
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
To determine the maximum tolerated dose (MTD) of OPB-51602

Detailed description:

Arms:
arm 1: OPB-51602 1, 2, 4 and 6 mg/day oral once daily (QD) in a 4 week cycle

Interventions: intervention 1: OPB-51602
Intervention descriptions: intervention 1: once daily during the treatment period

Protocol document: